63 phenotypes from 7 alleles in 10 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
F3tm1.1Dwr/F3tm1.1Dwr B6.129-F3tm1.1Dwr	abnormal induced retina neovascularization	J:135087
F3tm1.1Dwr/F3tm1.1Dwr involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6	normal hematopoietic system phenotype	J:71271
F3tm1.1Dwr/F3tm1.1Dwr involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss	abnormal blood coagulation	J:91165
	abnormal cellular extravasation	J:91165
	abnormal leukocyte adhesion	J:91165
	abnormal vascular smooth muscle physiology	J:111390
	abnormal vascular wound healing	J:111390
	decreased B cell number	J:91165
	decreased circulating interleukin-1 beta level	J:91165
	decreased circulating interleukin-6 level	J:91165
	decreased circulating tumor necrosis factor level	J:91165
	decreased leukocyte cell number	J:91165
	decreased neutrophil cell number	J:91165
	decreased susceptibility to endotoxin shock	J:91165
	decreased susceptibility to induced morbidity/mortality	J:91165
	impaired leukocyte tethering or rolling	J:91165
	increased vascular smooth muscle cell proliferation	J:111390
F3tm1Dco/F3tm1Dco Not Specified	abnormal embryo development	J:35120
	abnormal embryonic tissue morphology	J:35120
	abnormal extraembryonic tissue morphology	J:35120
	abnormal vitelline vasculature morphology	J:35120
	absent vitelline blood vessels	J:35120
	disorganized yolk sac vascular plexus	J:35120
	embryo tissue necrosis	J:35120
	embryonic lethality during organogenesis, complete penetrance	J:35120
	enlarged pericardium	J:35120
	pale yolk sac	J:35120
	pallor	J:35120
F3tm1Dwr/F3+ involves: 129S1/Sv * 129X1/SvJ	abnormal blood coagulation	J:99260
	abnormal thrombosis	J:99260
	decreased partial thromboplastin time	J:99260
	increased circulating factor IX level	J:99260
	increased circulating factor VIII level	J:99260
	increased circulating factor XI level	J:99260
	postnatal lethality	J:99260
	pregnancy-related premature death	J:99260
	premature death	J:99260
F3tm1Dwr/F3tm1Dwr involves: 129S1/Sv * 129X1/SvJ	abnormal atrial thrombosis	J:99260
	abnormal cardiac thrombosis	J:99260
	abnormal thrombosis	J:99260
	abnormal ventricular thrombosis	J:99260
	neonatal lethality, incomplete penetrance	J:99260
	premature death	J:99260
F3tm1Fct/F3tm1Fct involves: 129P2/OlaHsd * C57BL/6J	abnormal blood coagulation	J:216519
	abnormal embryonic erythrocyte morphology	J:216519
	abnormal extraembryonic mesoderm development	J:216519
	abnormal vitelline vasculature morphology	J:216519
	embryonic growth retardation	J:216519
	embryonic lethality during organogenesis, complete penetrance	J:216519
F3tm1Gjb/F3+ involves: 129X1/SvJ * C57BL/6	abnormal chemokine secretion	J:128891
	abnormal macrophage physiology	J:128891
	decreased interleukin-6 secretion	J:128891
	normal immune system phenotype	J:128891
F3tm1Gjb/F3tm1Gjb involves: 129S6/SvEvTac * 129X1/SvJ	embryonic lethality during organogenesis, complete penetrance	J:41500
F3tm1Gjb/F3tm1Gjb involves: 129X1/SvJ * C57BL/6	abnormal forebrain development	J:35037
	abnormal heart morphology	J:35037
	ataxia	J:41500
	blindness	J:41500
	decreased body weight	J:41500
	decreased embryo size	J:35037
	embryonic growth retardation	J:35037
	embryonic lethality during organogenesis, incomplete penetrance	J:35037, J:41500
	hemorrhage	J:41500
	internal hemorrhage	J:41500
	intracerebral hemorrhage	J:41500
	pale yolk sac	J:35037
	pallor	J:35037
	postnatal lethality, complete penetrance	J:41500
	prenatal lethality, complete penetrance	J:35037
F3tm1Jld/F3+ involves: 129P2/OlaHsd * NIH Black Swiss	abnormal blood coagulation	J:33831
F3tm1Jld/F3tm1Jld involves: 129P2/OlaHsd * NIH Black Swiss	abnormal blood vessel physiology	J:33831
	abnormal embryonic erythrocyte morphology	J:33831
	abnormal forebrain development	J:33831
	abnormal vitelline vasculature morphology	J:33831
	distended pericardium	J:33831
	embryo tissue necrosis	J:33831
	embryonic growth retardation	J:33831
	embryonic lethality during organogenesis, complete penetrance	J:33831
	enlarged heart	J:33831
	hemorrhage	J:33831
	pale yolk sac	J:33831
	pallor	J:33831
F3tm1Nmk/F3tm1Nmk Myl2tm1(cre)Krc/? involves: 129S4/SvJae * 129S6/SvEvTac	cardiac fibrosis	J:137921